nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—BCHE—Irinotecan—colon cancer	0.342	1	CbGbCtD
Ramipril—ACE—vein—colon cancer	0.0354	0.196	CbGeAlD
Ramipril—ACE—umbilical vein—colon cancer	0.0257	0.142	CbGeAlD
Ramipril—ACE—endothelium—colon cancer	0.0122	0.0673	CbGeAlD
Ramipril—ACE—blood vessel—colon cancer	0.0112	0.0621	CbGeAlD
Ramipril—SLC15A1—epithelium—colon cancer	0.00762	0.0422	CbGeAlD
Ramipril—SLC15A1—renal system—colon cancer	0.00707	0.0391	CbGeAlD
Ramipril—ACE—embryo—colon cancer	0.00669	0.037	CbGeAlD
Ramipril—SLC15A1—digestive system—colon cancer	0.0058	0.0321	CbGeAlD
Ramipril—ACE—epithelium—colon cancer	0.00546	0.0302	CbGeAlD
Ramipril—ACE—smooth muscle tissue—colon cancer	0.00526	0.0291	CbGeAlD
Ramipril—SLC15A1—vagina—colon cancer	0.00512	0.0283	CbGeAlD
Ramipril—ACE—renal system—colon cancer	0.00507	0.028	CbGeAlD
Ramipril—Mitiglinide—PPARG—colon cancer	0.00452	0.342	CrCbGaD
Ramipril—SLC15A2—renal system—colon cancer	0.00442	0.0244	CbGeAlD
Ramipril—SLC15A1—liver—colon cancer	0.00432	0.0239	CbGeAlD
Ramipril—ACE—lymphoid tissue—colon cancer	0.00421	0.0233	CbGeAlD
Ramipril—ACE—digestive system—colon cancer	0.00416	0.023	CbGeAlD
Ramipril—BCHE—smooth muscle tissue—colon cancer	0.00389	0.0215	CbGeAlD
Ramipril—ACE—bone marrow—colon cancer	0.00383	0.0212	CbGeAlD
Ramipril—SLC15A2—vagina—colon cancer	0.0032	0.0177	CbGeAlD
Ramipril—ACE—liver—colon cancer	0.0031	0.0171	CbGeAlD
Ramipril—BCHE—digestive system—colon cancer	0.00307	0.017	CbGeAlD
Ramipril—BCHE—bone marrow—colon cancer	0.00283	0.0157	CbGeAlD
Ramipril—BCHE—vagina—colon cancer	0.00271	0.015	CbGeAlD
Ramipril—ACE—lymph node—colon cancer	0.00237	0.0131	CbGeAlD
Ramipril—Nateglinide—PPARG—colon cancer	0.0023	0.174	CrCbGaD
Ramipril—BCHE—liver—colon cancer	0.00229	0.0127	CbGeAlD
Ramipril—SLC15A2—lymph node—colon cancer	0.00207	0.0115	CbGeAlD
Ramipril—Perindopril—ABCB1—colon cancer	0.00187	0.142	CrCbGaD
Ramipril—BCHE—lymph node—colon cancer	0.00175	0.0097	CbGeAlD
Ramipril—Cilazapril—ABCB1—colon cancer	0.00165	0.125	CrCbGaD
Ramipril—Lisinopril—ABCB1—colon cancer	0.00165	0.125	CrCbGaD
Ramipril—Enalapril—ABCB1—colon cancer	0.00121	0.0917	CrCbGaD
Ramipril—Dermatitis exfoliative—Methotrexate—colon cancer	0.000981	0.00212	CcSEcCtD
Ramipril—Photosensitivity reaction—Capecitabine—colon cancer	0.000981	0.00212	CcSEcCtD
Ramipril—Myalgia—Vincristine—colon cancer	0.000978	0.00211	CcSEcCtD
Ramipril—Weight increased—Capecitabine—colon cancer	0.000978	0.00211	CcSEcCtD
Ramipril—Cough—Irinotecan—colon cancer	0.000976	0.00211	CcSEcCtD
Ramipril—Leukopenia—Fluorouracil—colon cancer	0.000959	0.00207	CcSEcCtD
Ramipril—Anaphylactoid reaction—Methotrexate—colon cancer	0.000956	0.00206	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00095	0.00205	CcSEcCtD
Ramipril—Acute coronary syndrome—Capecitabine—colon cancer	0.000944	0.00204	CcSEcCtD
Ramipril—Cerebrovascular accident—Methotrexate—colon cancer	0.000944	0.00204	CcSEcCtD
Ramipril—Renal failure—Capecitabine—colon cancer	0.000942	0.00203	CcSEcCtD
Ramipril—Discomfort—Irinotecan—colon cancer	0.000941	0.00203	CcSEcCtD
Ramipril—Myocardial infarction—Capecitabine—colon cancer	0.000939	0.00203	CcSEcCtD
Ramipril—Neuropathy peripheral—Capecitabine—colon cancer	0.000939	0.00203	CcSEcCtD
Ramipril—Oedema—Vincristine—colon cancer	0.000938	0.00202	CcSEcCtD
Ramipril—Anaphylactic shock—Vincristine—colon cancer	0.000938	0.00202	CcSEcCtD
Ramipril—Stomatitis—Capecitabine—colon cancer	0.000934	0.00201	CcSEcCtD
Ramipril—Jaundice—Capecitabine—colon cancer	0.000934	0.00201	CcSEcCtD
Ramipril—Conjunctivitis—Capecitabine—colon cancer	0.000931	0.00201	CcSEcCtD
Ramipril—Urinary tract infection—Capecitabine—colon cancer	0.000931	0.00201	CcSEcCtD
Ramipril—Convulsion—Fluorouracil—colon cancer	0.000928	0.002	CcSEcCtD
Ramipril—Confusional state—Irinotecan—colon cancer	0.000921	0.00199	CcSEcCtD
Ramipril—Nervous system disorder—Vincristine—colon cancer	0.000919	0.00198	CcSEcCtD
Ramipril—Thrombocytopenia—Vincristine—colon cancer	0.000918	0.00198	CcSEcCtD
Ramipril—Oedema—Irinotecan—colon cancer	0.000913	0.00197	CcSEcCtD
Ramipril—Anaphylactic shock—Irinotecan—colon cancer	0.000913	0.00197	CcSEcCtD
Ramipril—Chest pain—Fluorouracil—colon cancer	0.000912	0.00197	CcSEcCtD
Ramipril—Myalgia—Fluorouracil—colon cancer	0.000912	0.00197	CcSEcCtD
Ramipril—Hyperhidrosis—Vincristine—colon cancer	0.000906	0.00195	CcSEcCtD
Ramipril—Hepatobiliary disease—Capecitabine—colon cancer	0.000906	0.00195	CcSEcCtD
Ramipril—Epistaxis—Capecitabine—colon cancer	0.000904	0.00195	CcSEcCtD
Ramipril—Discomfort—Fluorouracil—colon cancer	0.000901	0.00194	CcSEcCtD
Ramipril—Shock—Irinotecan—colon cancer	0.000898	0.00194	CcSEcCtD
Ramipril—Nervous system disorder—Irinotecan—colon cancer	0.000895	0.00193	CcSEcCtD
Ramipril—Agranulocytosis—Capecitabine—colon cancer	0.000894	0.00193	CcSEcCtD
Ramipril—Thrombocytopenia—Irinotecan—colon cancer	0.000894	0.00193	CcSEcCtD
Ramipril—Anorexia—Vincristine—colon cancer	0.000894	0.00193	CcSEcCtD
Ramipril—Hyperhidrosis—Irinotecan—colon cancer	0.000883	0.0019	CcSEcCtD
Ramipril—Confusional state—Fluorouracil—colon cancer	0.000882	0.0019	CcSEcCtD
Ramipril—Hypotension—Vincristine—colon cancer	0.000876	0.00189	CcSEcCtD
Ramipril—Oedema—Fluorouracil—colon cancer	0.000874	0.00189	CcSEcCtD
Ramipril—Anaphylactic shock—Fluorouracil—colon cancer	0.000874	0.00189	CcSEcCtD
Ramipril—Anorexia—Irinotecan—colon cancer	0.00087	0.00188	CcSEcCtD
Ramipril—Hepatitis—Capecitabine—colon cancer	0.00086	0.00186	CcSEcCtD
Ramipril—Nervous system disorder—Fluorouracil—colon cancer	0.000858	0.00185	CcSEcCtD
Ramipril—Thrombocytopenia—Fluorouracil—colon cancer	0.000856	0.00185	CcSEcCtD
Ramipril—Liver function test abnormal—Methotrexate—colon cancer	0.000854	0.00184	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Vincristine—colon cancer	0.000854	0.00184	CcSEcCtD
Ramipril—Tachycardia—Fluorouracil—colon cancer	0.000853	0.00184	CcSEcCtD
Ramipril—Hypotension—Irinotecan—colon cancer	0.000853	0.00184	CcSEcCtD
Ramipril—Insomnia—Vincristine—colon cancer	0.000848	0.00183	CcSEcCtD
Ramipril—Oedema peripheral—Capecitabine—colon cancer	0.000847	0.00183	CcSEcCtD
Ramipril—Connective tissue disorder—Capecitabine—colon cancer	0.000845	0.00182	CcSEcCtD
Ramipril—Paraesthesia—Vincristine—colon cancer	0.000842	0.00182	CcSEcCtD
Ramipril—Breast disorder—Methotrexate—colon cancer	0.000836	0.0018	CcSEcCtD
Ramipril—Anorexia—Fluorouracil—colon cancer	0.000834	0.0018	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000833	0.0018	CcSEcCtD
Ramipril—Visual impairment—Capecitabine—colon cancer	0.000829	0.00179	CcSEcCtD
Ramipril—Insomnia—Irinotecan—colon cancer	0.000826	0.00178	CcSEcCtD
Ramipril—Paraesthesia—Irinotecan—colon cancer	0.00082	0.00177	CcSEcCtD
Ramipril—Hypotension—Fluorouracil—colon cancer	0.000817	0.00176	CcSEcCtD
Ramipril—Decreased appetite—Vincristine—colon cancer	0.000815	0.00176	CcSEcCtD
Ramipril—Dyspnoea—Irinotecan—colon cancer	0.000814	0.00176	CcSEcCtD
Ramipril—Erythema multiforme—Capecitabine—colon cancer	0.000813	0.00175	CcSEcCtD
Ramipril—Somnolence—Irinotecan—colon cancer	0.000812	0.00175	CcSEcCtD
Ramipril—Gastrointestinal disorder—Vincristine—colon cancer	0.000809	0.00175	CcSEcCtD
Ramipril—Fatigue—Vincristine—colon cancer	0.000808	0.00174	CcSEcCtD
Ramipril—Dyspepsia—Irinotecan—colon cancer	0.000804	0.00173	CcSEcCtD
Ramipril—Tinnitus—Capecitabine—colon cancer	0.000802	0.00173	CcSEcCtD
Ramipril—Constipation—Vincristine—colon cancer	0.000802	0.00173	CcSEcCtD
Ramipril—Asthma—Methotrexate—colon cancer	0.0008	0.00173	CcSEcCtD
Ramipril—Flushing—Capecitabine—colon cancer	0.000798	0.00172	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000797	0.00172	CcSEcCtD
Ramipril—Decreased appetite—Irinotecan—colon cancer	0.000794	0.00171	CcSEcCtD
Ramipril—Eosinophilia—Methotrexate—colon cancer	0.000792	0.00171	CcSEcCtD
Ramipril—Insomnia—Fluorouracil—colon cancer	0.000791	0.00171	CcSEcCtD
Ramipril—Gastrointestinal disorder—Irinotecan—colon cancer	0.000788	0.0017	CcSEcCtD
Ramipril—Fatigue—Irinotecan—colon cancer	0.000787	0.0017	CcSEcCtD
Ramipril—Paraesthesia—Fluorouracil—colon cancer	0.000785	0.00169	CcSEcCtD
Ramipril—Pancreatitis—Methotrexate—colon cancer	0.000784	0.00169	CcSEcCtD
Ramipril—Constipation—Irinotecan—colon cancer	0.000781	0.00168	CcSEcCtD
Ramipril—Dyspnoea—Fluorouracil—colon cancer	0.00078	0.00168	CcSEcCtD
Ramipril—Somnolence—Fluorouracil—colon cancer	0.000777	0.00168	CcSEcCtD
Ramipril—Immune system disorder—Capecitabine—colon cancer	0.000777	0.00168	CcSEcCtD
Ramipril—Mediastinal disorder—Capecitabine—colon cancer	0.000775	0.00167	CcSEcCtD
Ramipril—Dyspepsia—Fluorouracil—colon cancer	0.00077	0.00166	CcSEcCtD
Ramipril—Arrhythmia—Capecitabine—colon cancer	0.000768	0.00166	CcSEcCtD
Ramipril—Abdominal discomfort—Methotrexate—colon cancer	0.000767	0.00165	CcSEcCtD
Ramipril—Gastrointestinal pain—Vincristine—colon cancer	0.000767	0.00165	CcSEcCtD
Ramipril—Decreased appetite—Fluorouracil—colon cancer	0.00076	0.00164	CcSEcCtD
Ramipril—Alopecia—Capecitabine—colon cancer	0.00076	0.00164	CcSEcCtD
Ramipril—Pancytopenia—Methotrexate—colon cancer	0.00076	0.00164	CcSEcCtD
Ramipril—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000755	0.00163	CcSEcCtD
Ramipril—Mental disorder—Capecitabine—colon cancer	0.000754	0.00163	CcSEcCtD
Ramipril—Feeling abnormal—Irinotecan—colon cancer	0.000752	0.00162	CcSEcCtD
Ramipril—Erythema—Capecitabine—colon cancer	0.000749	0.00161	CcSEcCtD
Ramipril—Malnutrition—Capecitabine—colon cancer	0.000749	0.00161	CcSEcCtD
Ramipril—Neutropenia—Methotrexate—colon cancer	0.000748	0.00161	CcSEcCtD
Ramipril—Gastrointestinal pain—Irinotecan—colon cancer	0.000747	0.00161	CcSEcCtD
Ramipril—Upper respiratory tract infection—Methotrexate—colon cancer	0.000743	0.0016	CcSEcCtD
Ramipril—Body temperature increased—Vincristine—colon cancer	0.000741	0.0016	CcSEcCtD
Ramipril—Abdominal pain—Vincristine—colon cancer	0.000741	0.0016	CcSEcCtD
Ramipril—Erectile dysfunction—Methotrexate—colon cancer	0.000737	0.00159	CcSEcCtD
Ramipril—Dysgeusia—Capecitabine—colon cancer	0.000733	0.00158	CcSEcCtD
Ramipril—Photosensitivity reaction—Methotrexate—colon cancer	0.00073	0.00157	CcSEcCtD
Ramipril—Abdominal pain—Irinotecan—colon cancer	0.000722	0.00156	CcSEcCtD
Ramipril—Body temperature increased—Irinotecan—colon cancer	0.000722	0.00156	CcSEcCtD
Ramipril—Feeling abnormal—Fluorouracil—colon cancer	0.000721	0.00155	CcSEcCtD
Ramipril—Muscle spasms—Capecitabine—colon cancer	0.00072	0.00155	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000707	0.00153	CcSEcCtD
Ramipril—Tremor—Capecitabine—colon cancer	0.000701	0.00151	CcSEcCtD
Ramipril—Renal failure—Methotrexate—colon cancer	0.000701	0.00151	CcSEcCtD
Ramipril—Stomatitis—Methotrexate—colon cancer	0.000695	0.0015	CcSEcCtD
Ramipril—Ill-defined disorder—Capecitabine—colon cancer	0.000695	0.0015	CcSEcCtD
Ramipril—Urticaria—Fluorouracil—colon cancer	0.000695	0.0015	CcSEcCtD
Ramipril—Conjunctivitis—Methotrexate—colon cancer	0.000693	0.0015	CcSEcCtD
Ramipril—Body temperature increased—Fluorouracil—colon cancer	0.000691	0.00149	CcSEcCtD
Ramipril—Hypersensitivity—Vincristine—colon cancer	0.000691	0.00149	CcSEcCtD
Ramipril—Sweating—Methotrexate—colon cancer	0.000684	0.00147	CcSEcCtD
Ramipril—Malaise—Capecitabine—colon cancer	0.000675	0.00146	CcSEcCtD
Ramipril—Hepatobiliary disease—Methotrexate—colon cancer	0.000675	0.00145	CcSEcCtD
Ramipril—Epistaxis—Methotrexate—colon cancer	0.000673	0.00145	CcSEcCtD
Ramipril—Vertigo—Capecitabine—colon cancer	0.000673	0.00145	CcSEcCtD
Ramipril—Hypersensitivity—Irinotecan—colon cancer	0.000673	0.00145	CcSEcCtD
Ramipril—Asthenia—Vincristine—colon cancer	0.000673	0.00145	CcSEcCtD
Ramipril—Syncope—Capecitabine—colon cancer	0.000671	0.00145	CcSEcCtD
Ramipril—Leukopenia—Capecitabine—colon cancer	0.00067	0.00145	CcSEcCtD
Ramipril—Agranulocytosis—Methotrexate—colon cancer	0.000666	0.00144	CcSEcCtD
Ramipril—Palpitations—Capecitabine—colon cancer	0.000662	0.00143	CcSEcCtD
Ramipril—Loss of consciousness—Capecitabine—colon cancer	0.000658	0.00142	CcSEcCtD
Ramipril—Asthenia—Irinotecan—colon cancer	0.000655	0.00141	CcSEcCtD
Ramipril—Cough—Capecitabine—colon cancer	0.000653	0.00141	CcSEcCtD
Ramipril—Hypersensitivity—Fluorouracil—colon cancer	0.000644	0.00139	CcSEcCtD
Ramipril—Diarrhoea—Vincristine—colon cancer	0.000641	0.00138	CcSEcCtD
Ramipril—Hepatitis—Methotrexate—colon cancer	0.00064	0.00138	CcSEcCtD
Ramipril—Arthralgia—Capecitabine—colon cancer	0.000637	0.00137	CcSEcCtD
Ramipril—Chest pain—Capecitabine—colon cancer	0.000637	0.00137	CcSEcCtD
Ramipril—Myalgia—Capecitabine—colon cancer	0.000637	0.00137	CcSEcCtD
Ramipril—Anxiety—Capecitabine—colon cancer	0.000635	0.00137	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000633	0.00137	CcSEcCtD
Ramipril—Discomfort—Capecitabine—colon cancer	0.00063	0.00136	CcSEcCtD
Ramipril—Diarrhoea—Irinotecan—colon cancer	0.000625	0.00135	CcSEcCtD
Ramipril—Dry mouth—Capecitabine—colon cancer	0.000623	0.00134	CcSEcCtD
Ramipril—Dizziness—Vincristine—colon cancer	0.00062	0.00134	CcSEcCtD
Ramipril—Pruritus—Fluorouracil—colon cancer	0.000619	0.00133	CcSEcCtD
Ramipril—Visual impairment—Methotrexate—colon cancer	0.000617	0.00133	CcSEcCtD
Ramipril—Confusional state—Capecitabine—colon cancer	0.000616	0.00133	CcSEcCtD
Ramipril—Oedema—Capecitabine—colon cancer	0.000611	0.00132	CcSEcCtD
Ramipril—Erythema multiforme—Methotrexate—colon cancer	0.000605	0.00131	CcSEcCtD
Ramipril—Dizziness—Irinotecan—colon cancer	0.000604	0.0013	CcSEcCtD
Ramipril—Shock—Capecitabine—colon cancer	0.000601	0.0013	CcSEcCtD
Ramipril—Nervous system disorder—Capecitabine—colon cancer	0.000599	0.00129	CcSEcCtD
Ramipril—Diarrhoea—Fluorouracil—colon cancer	0.000598	0.00129	CcSEcCtD
Ramipril—Thrombocytopenia—Capecitabine—colon cancer	0.000598	0.00129	CcSEcCtD
Ramipril—Tinnitus—Methotrexate—colon cancer	0.000597	0.00129	CcSEcCtD
Ramipril—Tachycardia—Capecitabine—colon cancer	0.000596	0.00129	CcSEcCtD
Ramipril—Vomiting—Vincristine—colon cancer	0.000596	0.00129	CcSEcCtD
Ramipril—Skin disorder—Capecitabine—colon cancer	0.000594	0.00128	CcSEcCtD
Ramipril—Rash—Vincristine—colon cancer	0.000591	0.00127	CcSEcCtD
Ramipril—Hyperhidrosis—Capecitabine—colon cancer	0.000591	0.00127	CcSEcCtD
Ramipril—Dermatitis—Vincristine—colon cancer	0.000591	0.00127	CcSEcCtD
Ramipril—Headache—Vincristine—colon cancer	0.000587	0.00127	CcSEcCtD
Ramipril—Anorexia—Capecitabine—colon cancer	0.000582	0.00126	CcSEcCtD
Ramipril—Vomiting—Irinotecan—colon cancer	0.000581	0.00125	CcSEcCtD
Ramipril—Immune system disorder—Methotrexate—colon cancer	0.000578	0.00125	CcSEcCtD
Ramipril—Dizziness—Fluorouracil—colon cancer	0.000578	0.00125	CcSEcCtD
Ramipril—Mediastinal disorder—Methotrexate—colon cancer	0.000577	0.00124	CcSEcCtD
Ramipril—Rash—Irinotecan—colon cancer	0.000576	0.00124	CcSEcCtD
Ramipril—Dermatitis—Irinotecan—colon cancer	0.000575	0.00124	CcSEcCtD
Ramipril—Headache—Irinotecan—colon cancer	0.000572	0.00123	CcSEcCtD
Ramipril—Hypotension—Capecitabine—colon cancer	0.000571	0.00123	CcSEcCtD
Ramipril—Alopecia—Methotrexate—colon cancer	0.000566	0.00122	CcSEcCtD
Ramipril—Mental disorder—Methotrexate—colon cancer	0.000561	0.00121	CcSEcCtD
Ramipril—Erythema—Methotrexate—colon cancer	0.000557	0.0012	CcSEcCtD
Ramipril—Malnutrition—Methotrexate—colon cancer	0.000557	0.0012	CcSEcCtD
Ramipril—Nausea—Vincristine—colon cancer	0.000557	0.0012	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000557	0.0012	CcSEcCtD
Ramipril—Vomiting—Fluorouracil—colon cancer	0.000556	0.0012	CcSEcCtD
Ramipril—Insomnia—Capecitabine—colon cancer	0.000553	0.00119	CcSEcCtD
Ramipril—Rash—Fluorouracil—colon cancer	0.000551	0.00119	CcSEcCtD
Ramipril—Dermatitis—Fluorouracil—colon cancer	0.000551	0.00119	CcSEcCtD
Ramipril—Paraesthesia—Capecitabine—colon cancer	0.000549	0.00118	CcSEcCtD
Ramipril—Headache—Fluorouracil—colon cancer	0.000548	0.00118	CcSEcCtD
Ramipril—Dysgeusia—Methotrexate—colon cancer	0.000546	0.00118	CcSEcCtD
Ramipril—Dyspnoea—Capecitabine—colon cancer	0.000545	0.00117	CcSEcCtD
Ramipril—Nausea—Irinotecan—colon cancer	0.000542	0.00117	CcSEcCtD
Ramipril—Dyspepsia—Capecitabine—colon cancer	0.000538	0.00116	CcSEcCtD
Ramipril—Decreased appetite—Capecitabine—colon cancer	0.000531	0.00115	CcSEcCtD
Ramipril—Gastrointestinal disorder—Capecitabine—colon cancer	0.000528	0.00114	CcSEcCtD
Ramipril—Fatigue—Capecitabine—colon cancer	0.000527	0.00114	CcSEcCtD
Ramipril—Constipation—Capecitabine—colon cancer	0.000523	0.00113	CcSEcCtD
Ramipril—Nausea—Fluorouracil—colon cancer	0.000519	0.00112	CcSEcCtD
Ramipril—Ill-defined disorder—Methotrexate—colon cancer	0.000517	0.00112	CcSEcCtD
Ramipril—Feeling abnormal—Capecitabine—colon cancer	0.000504	0.00109	CcSEcCtD
Ramipril—Malaise—Methotrexate—colon cancer	0.000503	0.00108	CcSEcCtD
Ramipril—Vertigo—Methotrexate—colon cancer	0.000501	0.00108	CcSEcCtD
Ramipril—Gastrointestinal pain—Capecitabine—colon cancer	0.0005	0.00108	CcSEcCtD
Ramipril—Leukopenia—Methotrexate—colon cancer	0.000499	0.00108	CcSEcCtD
Ramipril—Cough—Methotrexate—colon cancer	0.000486	0.00105	CcSEcCtD
Ramipril—Urticaria—Capecitabine—colon cancer	0.000485	0.00105	CcSEcCtD
Ramipril—Abdominal pain—Capecitabine—colon cancer	0.000483	0.00104	CcSEcCtD
Ramipril—Body temperature increased—Capecitabine—colon cancer	0.000483	0.00104	CcSEcCtD
Ramipril—Convulsion—Methotrexate—colon cancer	0.000483	0.00104	CcSEcCtD
Ramipril—Arthralgia—Methotrexate—colon cancer	0.000475	0.00102	CcSEcCtD
Ramipril—Myalgia—Methotrexate—colon cancer	0.000475	0.00102	CcSEcCtD
Ramipril—Chest pain—Methotrexate—colon cancer	0.000475	0.00102	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000471	0.00102	CcSEcCtD
Ramipril—Discomfort—Methotrexate—colon cancer	0.000469	0.00101	CcSEcCtD
Ramipril—Confusional state—Methotrexate—colon cancer	0.000459	0.000989	CcSEcCtD
Ramipril—Anaphylactic shock—Methotrexate—colon cancer	0.000455	0.000981	CcSEcCtD
Ramipril—Hypersensitivity—Capecitabine—colon cancer	0.00045	0.000971	CcSEcCtD
Ramipril—Nervous system disorder—Methotrexate—colon cancer	0.000446	0.000962	CcSEcCtD
Ramipril—Thrombocytopenia—Methotrexate—colon cancer	0.000445	0.000961	CcSEcCtD
Ramipril—Skin disorder—Methotrexate—colon cancer	0.000442	0.000953	CcSEcCtD
Ramipril—Hyperhidrosis—Methotrexate—colon cancer	0.00044	0.000948	CcSEcCtD
Ramipril—Asthenia—Capecitabine—colon cancer	0.000438	0.000946	CcSEcCtD
Ramipril—Anorexia—Methotrexate—colon cancer	0.000434	0.000935	CcSEcCtD
Ramipril—Pruritus—Capecitabine—colon cancer	0.000432	0.000932	CcSEcCtD
Ramipril—Hypotension—Methotrexate—colon cancer	0.000425	0.000917	CcSEcCtD
Ramipril—Diarrhoea—Capecitabine—colon cancer	0.000418	0.000902	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000414	0.000894	CcSEcCtD
Ramipril—Insomnia—Methotrexate—colon cancer	0.000411	0.000887	CcSEcCtD
Ramipril—Paraesthesia—Methotrexate—colon cancer	0.000408	0.000881	CcSEcCtD
Ramipril—Dyspnoea—Methotrexate—colon cancer	0.000406	0.000875	CcSEcCtD
Ramipril—Somnolence—Methotrexate—colon cancer	0.000404	0.000872	CcSEcCtD
Ramipril—Dizziness—Capecitabine—colon cancer	0.000404	0.000872	CcSEcCtD
Ramipril—Dyspepsia—Methotrexate—colon cancer	0.0004	0.000864	CcSEcCtD
Ramipril—Decreased appetite—Methotrexate—colon cancer	0.000395	0.000853	CcSEcCtD
Ramipril—Gastrointestinal disorder—Methotrexate—colon cancer	0.000393	0.000847	CcSEcCtD
Ramipril—Fatigue—Methotrexate—colon cancer	0.000392	0.000846	CcSEcCtD
Ramipril—Vomiting—Capecitabine—colon cancer	0.000389	0.000838	CcSEcCtD
Ramipril—Rash—Capecitabine—colon cancer	0.000385	0.000831	CcSEcCtD
Ramipril—Dermatitis—Capecitabine—colon cancer	0.000385	0.00083	CcSEcCtD
Ramipril—Headache—Capecitabine—colon cancer	0.000383	0.000826	CcSEcCtD
Ramipril—Feeling abnormal—Methotrexate—colon cancer	0.000375	0.000808	CcSEcCtD
Ramipril—Gastrointestinal pain—Methotrexate—colon cancer	0.000372	0.000802	CcSEcCtD
Ramipril—Nausea—Capecitabine—colon cancer	0.000363	0.000783	CcSEcCtD
Ramipril—Urticaria—Methotrexate—colon cancer	0.000361	0.000779	CcSEcCtD
Ramipril—Body temperature increased—Methotrexate—colon cancer	0.00036	0.000776	CcSEcCtD
Ramipril—Abdominal pain—Methotrexate—colon cancer	0.00036	0.000776	CcSEcCtD
Ramipril—Hypersensitivity—Methotrexate—colon cancer	0.000335	0.000723	CcSEcCtD
Ramipril—Asthenia—Methotrexate—colon cancer	0.000326	0.000704	CcSEcCtD
Ramipril—Pruritus—Methotrexate—colon cancer	0.000322	0.000694	CcSEcCtD
Ramipril—Diarrhoea—Methotrexate—colon cancer	0.000311	0.000671	CcSEcCtD
Ramipril—Dizziness—Methotrexate—colon cancer	0.000301	0.000649	CcSEcCtD
Ramipril—Vomiting—Methotrexate—colon cancer	0.000289	0.000624	CcSEcCtD
Ramipril—Rash—Methotrexate—colon cancer	0.000287	0.000619	CcSEcCtD
Ramipril—Dermatitis—Methotrexate—colon cancer	0.000287	0.000618	CcSEcCtD
Ramipril—Headache—Methotrexate—colon cancer	0.000285	0.000615	CcSEcCtD
Ramipril—Nausea—Methotrexate—colon cancer	0.00027	0.000583	CcSEcCtD
